Skip to main content
TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.25
+1.12 (8.53%)
Nov 11, 2026, 4:00 PM EST - Market closed

TRex Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Market Capitalization
384--
Market Cap Growth
---
Enterprise Value
293--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.000.010.01
Net Debt / Equity Ratio
-1.03-1.00-1.09
Net Debt / EBITDA Ratio
1.841.7857.58
Net Debt / FCF Ratio
1.961.622.52
Quick Ratio
11.8713.568.66
Current Ratio
12.1814.308.86
Return on Equity (ROE)
--55.17%-
Return on Assets (ROA)
--33.50%-
Return on Capital Employed (ROCE)
-55.80%-55.50%-3.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
--5.23%-
SEC Filings: 10-K · 10-Q